Vicky Weichsler

Vicky Weichsler is an accomplished professional in biopharmaceuticals, currently serving as Program Head at Immunic Therapeutics since November 2024. Vicky has an extensive background in biosimilars, having held the position of Global Program Head at Sandoz from April 2014 to June 2020, where responsibilities included innovation, strategy, and operations for various biosimilar development programs, notably leading the successful Hyrimoz® program through clinical phases to regulatory approval and launch. Prior experience includes serving as Global Program Leader and Global Program Manager at Amgen Research (Munich) GmbH, where Vicky focused on drug development teams in oncology and autoimmune diseases, and as Project Manager at Micromet GmbH, overseeing drug development collaborations. Vicky holds an MSc in Organic Chemistry and Technology from Technische Universität Wien and has completed business administration education at WIFI Wien.